×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
BIOA – bioage labs, inc. (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
BIOA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/21
03:20 pm
bioa
BioArctic publishes the Annual Report and Sustainability Report for 2025
Low
Report
BioArctic publishes the Annual Report and Sustainability Report for 2025
4/21
03:17 pm
bioa
BioArctic publishes the Annual Report and Sustainability Report for 2025
Low
Report
BioArctic publishes the Annual Report and Sustainability Report for 2025
4/21
07:13 am
bioa
BioAge Reports Positive Phase 1 Data for BGE-102, a Novel Oral NLRP3 Inhibitor, Demonstrating Potential Best-in-Class Reductions in hsCRP [Yahoo! Finance]
Medium
Report
BioAge Reports Positive Phase 1 Data for BGE-102, a Novel Oral NLRP3 Inhibitor, Demonstrating Potential Best-in-Class Reductions in hsCRP [Yahoo! Finance]
4/21
07:00 am
bioa
BioAge Reports Positive Phase 1 Data for BGE-102, a Novel Oral NLRP3 Inhibitor, Demonstrating Potential Best-in-Class Reductions in hsCRP
Low
Report
BioAge Reports Positive Phase 1 Data for BGE-102, a Novel Oral NLRP3 Inhibitor, Demonstrating Potential Best-in-Class Reductions in hsCRP
4/16
07:31 pm
bioa
BioAge Labs Highlights BGE-102 Catalysts, DME Study Plans and $285M Cash at Needham Conference [Yahoo! Finance]
High
Report
BioAge Labs Highlights BGE-102 Catalysts, DME Study Plans and $285M Cash at Needham Conference [Yahoo! Finance]
4/15
04:26 pm
bioa
BioAge Labs: Oral NLRP3 Inhibitor Could Establish PoC In CV This Year [Seeking Alpha]
Low
Report
BioAge Labs: Oral NLRP3 Inhibitor Could Establish PoC In CV This Year [Seeking Alpha]
4/13
04:30 pm
bioa
BioAge Labs to Present at 25th Annual Needham Virtual Healthcare Conference
Low
Report
BioAge Labs to Present at 25th Annual Needham Virtual Healthcare Conference
3/27
08:02 am
bioa
BioAge Labs (BIOA) is now covered by Needham & Company LLC. They set a "buy" rating and a $50.00 price target on the stock.
Medium
Report
BioAge Labs (BIOA) is now covered by Needham & Company LLC. They set a "buy" rating and a $50.00 price target on the stock.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/21
04:26 pm
bioa
Form ARS BioAge Labs, Inc. For: Dec 31
Low
Report
Form ARS BioAge Labs, Inc. For: Dec 31
4/21
04:05 pm
bioa
Form DEF 14A BioAge Labs, Inc. For: Jun 10
Low
Report
Form DEF 14A BioAge Labs, Inc. For: Jun 10
4/3
04:07 pm
bioa
Form 4 BioAge Labs, Inc. For: Apr 01 Filed by: RUBIN PAUL D
Low
Report
Form 4 BioAge Labs, Inc. For: Apr 01 Filed by: RUBIN PAUL D
4/1
10:54 am
bioa
Form 144 BioAge Labs, Inc. Filed by: RUBIN PAUL D
Low
Report
Form 144 BioAge Labs, Inc. Filed by: RUBIN PAUL D
3/24
09:16 am
bioa
Form 10-K BioAge Labs, Inc. For: Dec 31
High
Report
Form 10-K BioAge Labs, Inc. For: Dec 31
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: